Symbicort® (budesonide/formoterol) Asthma

This website is intended for doctors, nurses, and pharmacists in the UK. Other UK residents please visit astrazeneca.co.uk.

Product information

Indication1-3

Symbicort® Turbohaler® is indicated in adults, adolescents aged 12 years and older, and children aged 6 years and older (100/6µg only), for the regular treatment of asthma where use of a combination (inhaled corticosteroid and long-acting β2-adrenoceptor agonist) is appropriate:

  • Patients not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β2-adrenoceptor agonists
  • Patients already adequately controlled on both inhaled corticosteroids and long-acting β2-adrenoceptor agonists